OpGen Inc Valuation

OPGNDelisted Stock  USD 1.90  0.15  7.32%   
Based on Macroaxis valuation methodology, the company appears to be overvalued. OpGen Inc holds a recent Real Value of $1.81 per share. The prevailing price of the company is $1.9. Our model determines the value of OpGen Inc from analyzing the company fundamentals such as return on equity of -3.15, and Current Valuation of 29.68 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
1.90
Please note that OpGen's price fluctuation is very steady at this time. Calculation of the real value of OpGen Inc is based on 3 months time horizon. Increasing OpGen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since OpGen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OpGen Pink Sheet. However, OpGen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.9 Real  1.81 Hype  1.9 Naive  2.13
The intrinsic value of OpGen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OpGen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.80
Real Value
2.09
Upside
Estimating the potential upside or downside of OpGen Inc helps investors to forecast how OpGen pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OpGen more accurately as focusing exclusively on OpGen's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.812.633.45
Details
Hype
Prediction
LowEstimatedHigh
1.901.901.90
Details
Naive
Forecast
LowNext ValueHigh
2.132.132.13
Details

OpGen Total Value Analysis

OpGen Inc is now forecasted to have valuation of 29.68 M with market capitalization of 16.38 M, debt of 13.04 M, and cash on hands of 10.28 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the OpGen fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
29.68 M
16.38 M
13.04 M
10.28 M

OpGen Investor Information

The company recorded a loss per share of 40.32. OpGen Inc last dividend was issued on the 29th of August 2019. The entity had 1:10 split on the 20th of May 2024. Based on the analysis of OpGen's profitability, liquidity, and operating efficiency, OpGen Inc is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in January.

OpGen Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. OpGen has an asset utilization ratio of 181.61 percent. This suggests that the Company is making $1.82 for each dollar of assets. An increasing asset utilization means that OpGen Inc is more efficient with each dollar of assets it utilizes for everyday operations.

OpGen Ownership Allocation

The market capitalization of OpGen Inc is $16.38 Million. OpGen holds 3.63 pct. of its outstanding shares held by insiders and 0.26 pct. owned by third-party entities. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.

OpGen Profitability Analysis

The company reported the previous year's revenue of 3.42 M. Net Loss for the year was (32.67 M) with loss before overhead, payroll, taxes, and interest of (8.99 M).

About OpGen Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of OpGen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of OpGen Inc based exclusively on its fundamental and basic technical indicators. By analyzing OpGen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of OpGen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of OpGen. We calculate exposure to OpGen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OpGen's related companies.
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. The company was incorporated in 2001 and is headquartered in Rockville, Maryland. Opgen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 91 people.

8 Steps to conduct OpGen's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates OpGen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct OpGen's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain OpGen's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine OpGen's revenue streams: Identify OpGen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research OpGen's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish OpGen's growth potential: Evaluate OpGen's management, business model, and growth potential.
  • Determine OpGen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate OpGen's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

OpGen Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding787.8 K
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in OpGen Pink Sheet

If you are still planning to invest in OpGen Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OpGen's history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories